GlassScriptPhysician profile
Mitchell Whigham
NPI 1659027217
$4,731.09
in general payments reported to CMS, 2019-2025
19 companies · $77.24 in 2025
The $77.24 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,455 · 2023: $2,949 · 2024: $250 · 2025: $77.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,275.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $838.92 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $799.29 | 2022-2025 | Spravato, Invega Sustenna, Invega Trinza |
| Otsuka America Pharmaceutical, INC. | $578.42 | 2022-2023 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $503.73 | 2022-2023 | |
| Teva Pharmaceuticals USA, INC. | $397.75 | 2022-2023 | Uzedy, Austedo Xr, Austedo |
| Alkermes, INC. | $374.15 | 2022-2023 | Aristada, Lybalvi |
| Vanda Pharmaceuticals INC. | $283.31 | 2022-2023 | Fanapt, Hetlioz |
| Merck Sharp & Dohme LLC | $191.49 | 2022-2023 | Belsomra |
| Neurocrine Biosciences, INC. | $179.78 | 2022-2023 | Ingrezza |
| Corium, LLC | $138.13 | 2022-2023 | Azstarys |
| Axsome Therapeutics, INC. | $85.98 | 2023 | Auvelity |
| Almatica Pharma LLC | $85.98 | 2022-2023 | Loreev Xr, Sertraline Hcl |
| Takeda Pharmaceuticals U.S.A., INC. | $68.61 | 2022-2023 | Trintellix |
| Ironshore Pharmaceuticals INC. | $64.98 | 2023 | Jornay Pm |
| Neos Therapeutics, LP | $43.48 | 2022-2023 | Adzenys Xr-Odt |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $42.55 | 2022-2023 | Rexulti |
| Sunovion Pharmaceuticals INC. | $31.13 | 2022 | |
| Arbor Pharmaceuticals, INC. | $13.76 | 2022 | |
| Janssen Biotech, INC. | $9.65 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Whigham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.